Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-25-064443
Filing Date
2025-07-01
Accepted
2025-07-01 08:30:23
Documents
5
Period of Report
2025-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2518776d1_6k.htm 6-K 28008
2 EXHIBIT 4.1 tm2518776d1_ex4-1.htm EX-4.1 77309
3 EXHIBIT 10.1 tm2518776d1_ex10-1.htm EX-10.1 337012
4 EXHIBIT 99.1 tm2518776d1_ex99-1.htm EX-99.1 15715
5 GRAPHIC tm2518776d1_ex99-1img001.jpg GRAPHIC 3967
  Complete submission text file 0001104659-25-064443.txt   464797
Mailing Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000
Business Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000 86-512-87773632
Adagene Inc. (Filer) CIK: 0001818838 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39997 | Film No.: 251094236
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)